9997 — Kangji Medical Holdings Cashflow Statement
0.000.00%
- HK$8.78bn
- HK$7.46bn
- CNY1.01bn
- 73
- 45
- 94
- 84
Annual cashflow statement for Kangji Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 310 | 534 | 563 | 589 | 685 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -1.19 | -74.6 | -58.3 | -86.5 | -84.9 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -96 | -36 | -207 | -116 | -67.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 221 | 436 | 319 | 420 | 560 |
Capital Expenditures | -17.8 | -31 | -115 | -87.9 | -55.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -593 | -129 | -255 | -304 | 1,096 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -611 | -160 | -370 | -392 | 1,041 |
Financing Cash Flow Items | -494 | -0.196 | -1.88 | 0 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2,152 | -97.6 | -473 | -244 | -1,696 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,565 | 143 | -439 | -219 | -100 |